ArticleArthritis & rheumatology (Hoboken, N.J.)2025

Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries.

Romain Aymon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.